Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Ncs Diagnostics Inc Canada"

08:45 EDT 17th April 2014 | BioPortfolio

Original Source: Somagen Diagnostics

Somagen was founded as Immucor Canada Inc. in 1988 by Thomas E Brown and Roland Person. In its early days the business focused on supplying the Canadian Blood Bank market. By 1995 the company had begun expanding into other niche laboratory markets and then acquired NCS Diagnostics in a significant step toward expansion. Kevin Blackburn, who would become the company's third partner, joined the business in 1996. Expansion into new markets within the clinical lab continued over the next several years. Immucor...

Matching Channels

Roche

Roche is the 5th largest pharmaceutical company in the world, based on annual sales, which were recorded at $36,017m in 2009. The pharmaceutical products of Roche are major players in the followin...

Hepatitis B Immune Globulin Cangene

HepaGam B® [Hepatitis B Immune Globulin (Human) Injection] contains purified antibodies specific for the hepatitis B surface antigen (HBsAg). * It is approved in Canada and the United States f...

Alto Marketing - specialist healthcare and life science communications consultancy

Alto Marketing is a committed and forward-thinking specialist healthcare and life science communications consultancy.  With extensive experience of worldwide marketing in sectors including (...

Siemens

Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Cambridge

In addition to the world famous Cambridge University, Cambridge and its surrounding area is a hub of globally reaching biotechnology companies. With more than 247 companies, and the high quality res...

Matching News

SQI Diagnostics obtains Health Canada license for celiac disease test kit

SQI Diagnostics, a life sciences and diagnostics company, has obtained marketing license from Health Canada for its multiplexed Ig_plex Celiac DGP panel, intended for use in clinical laboratories as a...

Qiagen, Exosome Diagnostics to develop diagnostics for cancer

Qiagen, a Netherlands-based holding company, has expanded its strategic partnership with Exosome Diagnostics to develop a first-in-class, non-invasive molecular in-vitro diagnostics for use in diagnos...

Qiagen, Exosome Diagnostics expand partnership to develop diagnostics for lung cancer

Netherlands-based Qgen and US-based Exosome Diagnostics have announced an expansion of their strategic partnership for developing non-invasive molecular in-vitro diagnostics for key genetic biomarkers...

SQI gains approval for celiac disease test in Canada

SQI Diagnostics has received the go-ahead in Canada to market its Ig_plex Celiac DGP Panel for clinical lab use.  -More- EU Commission Recommendation - Unannounced Audits On-Demand Webinar A...

EKF Molecular Diagnostics to exhibit PointMan DNA-enrichment technology at Tri-Con 2014

EKF Diagnostics, the global in vitro diagnostics business, announces that its subsidiary company EKF Molecular Diagnostics is exhibiting its ground-breaking PointMan DNA-enrichment technology at Tri-C...

MGC Diagnostics to acquire Medisoft

MGC Diagnostics, a global medical technologies company, has entered into a letter of intent to acquire Medisoft of Sorinnes, Belgium. MGC Diagnostics would acquire all the outstanding shares of Mediso...

CommunityWorks Canada: Government of Canada Announces Funding for Joint Venture between The Sinneave Family Foundation and Autism Speaks Canada

TORONTO, Feb. 13, 2014 (GLOBE NEWSWIRE) -- The Sinneave Family Foundation (SFF) and Autism Speaks Canada (ASC) alongside the federal government of Canada and the Honourable Jim Flaherty, Minister of...

Meridian Biosciences: Recent Sell-Off In Small Cap Stock With Great Growth Potential

By Nicholas Bodnar: Company Overview: Meridian Biosciences (VIVO) is a fully integrated life science company with business in, the development, manufacture, sale and distribution of diagnostic test...

Matching PubMed Articles

Physiotherapy Canada volume 65, annual index - 2013.

Point-of-Care Diagnostics in Low-Resource Settings and Their Impact on Care in the Age of the Noncommunicable and Chronic Disease Epidemic.

The emergence of point-of-care (POC) diagnostics specifically designed for low-resource settings coupled with the rapid increase in need for routine care of patients with chronic diseases should promp...

The difficulties encountered in diagnostics of malignant neoplasms of the middle ear in the children.

The objective of the present work was to estimate the potential of CT and MRI diagnostics of malignant neoplasms of the middle ear in the children. Diagnostics of these tumours encounters great diffic...

Structured diagnostics and therapy of the CUP syndrome.

In the majority of cases, patients with cancer of unknown primary (CUP) have a poor prognosis with no prospect of being cured. Hence, a reasonable focus of diagnostics on its essential targets seems a...

Clinician's Commentary on Armijo-Olivo et al.(1.).

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement